Article
SPP1 and AGER as potential prognostic biomarkers for lung adenocarcinoma
12 Mar 2018
Abstract excerpt
Overdue treatment and prognostic evaluation lead to low survival rates in patients with lung adenocarcinoma (LUAD). To date, effective biomarkers for prognosis are still required. The aim of the present study was to screen differentially expressed genes (DEGs) as biomarkers for prognostic evaluation of LUAD. DEGs in tumor and normal samples were identified and analyzed for Kyoto Encyclopedia of Genes and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
